University of Alberta
1,011
173
207
570
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
13.5%
136 terminated/withdrawn out of 1011 trials
80.7%
-5.8% vs industry average
11%
112 trials in Phase 3/4
10%
58 of 570 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1011)
Ultra-Early Gamma Knife Stereotactic Radiosurgery for TN
Role: lead
Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle
Role: lead
Cytolytic Vaginosis Multicentre Registry
Role: lead
An Adaptive Design Study of MTX228
Role: lead
My MS and My Menstrual Cycle
Role: lead
The Whole Day Matters After Stroke (BIG-STEPS)
Role: lead
Transpulmonary Assessment for Individualized Lung Optimization in Obese Patients
Role: lead
Use of a β-Glucan Cream in Incontinence-Associated Dermatitis
Role: lead
Micro-UltraSound In Cancer - Active Surveillance
Role: lead
GLA:D Back Canada - a Program for Chronic and Persistent Low Back Pain
Role: lead
Transcutaneous Spinal Cord Stimulation for Upper Extremity Function
Role: lead
Doxycycline to Protect Heart Muscle After Heart Attacks
Role: lead
rTMS With and Without Text4Support for the Treatment of Resistant Depression.
Role: lead
Safety, Tolerability and Efficacy of Nefopam Cream in Burn Patients
Role: lead
PET Perfusion Imaging Techniques and Comparing Them to CT Perfusion Imaging in Stroke
Role: lead
Study of Minimally-invasive Ablative Renal Therapies (SMART) Registry
Role: lead
Does the Format of the Adult ADHD Self-Report Scale Impact the Results
Role: lead
Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS
Role: lead
Does ESWT With BoNTA Treatment Improve Outcomes When Compared to Standard Management for Upper Limb Spasticity Patient.
Role: lead
Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease
Role: lead